Philogen S.p.A. announced that they have entered into a collaboration, option and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and develop a new class of immunomodulatory therapeutics.
News & Events
Philogen S.p.A. announced that they have entered into a collaboration
Last News & Events
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.